Suchen
Nyxoah SA
NYXHZur Watchlist hinzufügen
1.400USD
-0.010-0.71%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
60.24MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Nyxoah SA Unternehmen
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Nyxoah SA Informationen
BörsenkürzelNYXH
Name des UnternehmensNyxoah SA
IPO-datumSep 18, 2020
CEOTaelman (Olivier)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeSep 18
AddresseRue Edouard Belin 12
StadtMONT-SAINT-GUIBERT
BörseNASDAQ OMX - NASDAQ BASIC
LandBelgium
Postleitzahl1435
Telefon3226121755
Websitehttps://www.nyxoah.com/
BörsenkürzelNYXH
IPO-datumSep 18, 2020
CEOTaelman (Olivier)
Führungskräfte von Nyxoah SA
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Mr. Christoph Eigenmann
Mr. Christoph Eigenmann
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Daniel G. Wildman
Mr. Daniel G. Wildman
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Francis Kim
Mr. Francis Kim
Chief Regulatory and Quality Officer
Chief Regulatory and Quality Officer
--
--
Dr. Maurits S. Boon
Dr. Maurits S. Boon
Chief Medical Officer
Chief Medical Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Robert Taub
Mr. Robert Taub
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
14.44M
+70.15%
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Juergen Hambrecht, Ph.D.
Dr. Juergen Hambrecht, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Pierre Gianello, M.D.
Dr. Pierre Gianello, M.D.
Non-Executive Director
Non-Executive Director
--
--
Mr. Olivier Taelman
Mr. Olivier Taelman
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Nyxoah SA?
Die fünf größten Anteilseigner von Nyxoah SA sind: Mr. Robert Taub
Wie viele Institutionen halten Anteile an Nyxoah SA (NYXH)?
Mit Stand vom 2026Q1 halten 79 Institutionen Anteile an Nyxoah SA, mit einem Gesamtmarktwert von etwa 9.38M, was 21.47% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -824223.00 gestiegen.